PaxMedica (PXMD) Competitors $0.07 -0.03 (-33.02%) (As of 01:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends PXMD vs. SHPH, VRPX, GNPX, LIPO, ARAV, PCSA, ALBT, MYMD, PBM, and MTNBShould you be buying PaxMedica stock or one of its competitors? The main competitors of PaxMedica include Shuttle Pharmaceuticals (SHPH), Virpax Pharmaceuticals (VRPX), Genprex (GNPX), Lipella Pharmaceuticals (LIPO), Aravive (ARAV), Processa Pharmaceuticals (PCSA), Avalon GloboCare (ALBT), MyMD Pharmaceuticals (MYMD), Psyence Biomedical (PBM), and Matinas Biopharma (MTNB). These companies are all part of the "pharmaceutical products" industry. PaxMedica vs. Shuttle Pharmaceuticals Virpax Pharmaceuticals Genprex Lipella Pharmaceuticals Aravive Processa Pharmaceuticals Avalon GloboCare MyMD Pharmaceuticals Psyence Biomedical Matinas Biopharma PaxMedica (NASDAQ:PXMD) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, community ranking, dividends, institutional ownership, risk and earnings. Is PXMD or SHPH more profitable? Shuttle Pharmaceuticals' return on equity of -583.02% beat PaxMedica's return on equity.Company Net Margins Return on Equity Return on Assets PaxMedicaN/A -3,167.89% -560.35% Shuttle Pharmaceuticals N/A -583.02%-258.92% Which has better valuation & earnings, PXMD or SHPH? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPaxMedicaN/AN/A-$18.29MN/AN/AShuttle PharmaceuticalsN/AN/A-$6.59M-$4.15-0.21 Do insiders and institutionals have more ownership in PXMD or SHPH? 4.9% of PaxMedica shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 1.0% of PaxMedica shares are held by insiders. Comparatively, 39.6% of Shuttle Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more risk & volatility, PXMD or SHPH? PaxMedica has a beta of -0.62, suggesting that its stock price is 162% less volatile than the S&P 500. Comparatively, Shuttle Pharmaceuticals has a beta of -1.32, suggesting that its stock price is 232% less volatile than the S&P 500. Do analysts rate PXMD or SHPH? PaxMedica presently has a consensus target price of $3.00, suggesting a potential upside of 4,173.50%. Given PaxMedica's stronger consensus rating and higher probable upside, equities research analysts plainly believe PaxMedica is more favorable than Shuttle Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PaxMedica 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Shuttle Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to PXMD or SHPH? In the previous week, Shuttle Pharmaceuticals had 1 more articles in the media than PaxMedica. MarketBeat recorded 1 mentions for Shuttle Pharmaceuticals and 0 mentions for PaxMedica. Shuttle Pharmaceuticals' average media sentiment score of 0.66 beat PaxMedica's score of 0.00 indicating that Shuttle Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment PaxMedica Neutral Shuttle Pharmaceuticals Positive Does the MarketBeat Community prefer PXMD or SHPH? PaxMedica received 1 more outperform votes than Shuttle Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformPaxMedicaOutperform Votes1100.00% Underperform VotesNo VotesShuttle PharmaceuticalsN/AN/A SummaryPaxMedica and Shuttle Pharmaceuticals tied by winning 6 of the 12 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get PaxMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PXMD vs. The Competition Export to ExcelMetricPaxMedicaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.13M$6.48B$5.06B$8.89BDividend YieldN/A8.11%4.97%4.06%P/E RatioN/A4.8389.0213.30Price / SalesN/A372.991,207.2881.01Price / CashN/A52.2739.1736.03Price / Book0.237.876.085.74Net Income-$18.29M$153.61M$119.07M$225.93M7 Day Performance-5.67%-2.00%-1.84%-1.32%1 Month Performance-25.14%-7.47%-3.65%0.60%1 Year Performance-86.90%31.80%31.62%26.23% PaxMedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXMDPaxMedicaN/A$0.07-33.0%$3.00+4,173.5%-89.3%$794,000.00N/A0.002Gap DownSHPHShuttle Pharmaceuticals0.5243 of 5 stars$0.85-5.1%N/AN/A$3.12MN/A0.005VRPXVirpax Pharmaceuticals2.8979 of 5 stars$0.62+0.5%$3.00+383.9%-90.7%$3.03MN/A0.007Gap DownGNPXGenprex4.1663 of 5 stars$1.17+6.4%$10.00+754.6%-89.4%$3.03MN/A0.0020News CoveragePositive NewsLIPOLipella Pharmaceuticals2.9867 of 5 stars$2.50+3.7%$16.00+540.0%-74.3%$3.03M$450,000.00-0.604News CoverageARAVAravive0.8331 of 5 stars$0.04flatN/AN/A$2.95M$9.14M-0.0420High Trading VolumePCSAProcessa Pharmaceuticals3.2309 of 5 stars$0.90-1.1%$6.00+566.4%-89.3%$2.94MN/A0.0020News CoverageALBTAvalon GloboCare0.8367 of 5 stars$2.69-3.2%N/A-66.0%$2.93M$1.26M-0.135MYMDMyMD PharmaceuticalsN/A$1.23+7.0%N/A-87.3%$2.92MN/A0.009PBMPsyence BiomedicalN/A$0.05-8.2%N/AN/A$2.91MN/A0.00N/ANews CoverageMTNBMatinas Biopharma0.7173 of 5 stars$0.56+3.8%N/AN/A$2.85M$1.10M0.0030Gap Up Related Companies and Tools Related Companies SHPH Alternatives VRPX Alternatives GNPX Alternatives LIPO Alternatives ARAV Alternatives PCSA Alternatives ALBT Alternatives MYMD Alternatives PBM Alternatives MTNB Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PXMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PaxMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PaxMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PXMD Stock Alerts